Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional regulation of NDUFA4L2 by NFIB induces sorafenib resistance by decreasing reactive oxygen species in hepatocellular carcinoma. | Cancer Sci | 2023 | 36369883 | PubTator, text mining | PubMed |
| Small-molecule inhibition of the archetypal UbiB protein COQ8. | Nat Chem Biol | 2023 | 36302899 | PubTator, text mining | PubMed |
| Case-case genome-wide association analysis identifying genetic loci with divergent effects on Crohn's disease and ulcerative colitis. | Hum Mol Genet | 2023 | 36164742 | PubTator, text mining | PubMed |
| NOD2 in Crohn's Disease-Unfinished Business. | J Crohns Colitis | 2023 | 36006803 | PubTator, text mining | PubMed |
| Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic. | Biochemistry | 2023 | 35856839 | PubTator, text mining | PubMed |
| Ligandability of E3 Ligases for Targeted Protein Degradation Applications. | Biochemistry | 2023 | 34473924 | PubTator, text mining | PubMed |
| Genetics in Behcet's Disease: An Update Review. | Front Ophthalmol (Lausanne) | 2022 | 38983559 | PubTator, text mining | PubMed |
| Comparative transcriptome analysis of rainbow trout gonadal cells (RTG-2) infected with U and J genogroup infectious hematopoietic necrosis virus. | Front Microbiol | 2022 | 36733771 | PubTator, text mining | PubMed |
| Genotype-protein phenotype characterization of NOD2 and IL23R missense variants associated with inflammatory bowel disease: A paradigm from molecular modelling, dynamics, and docking simulations. | Front Med (Lausanne) | 2022 | 36703890 | PubTator, text mining | PubMed |
| Analysis of Long Noncoding RNAs-Related Regulatory Mechanisms in Duchenne Muscular Dystrophy Using a Disease-Related lncRNA-mRNA Pathway Network. | Genet Res (Camb) | 2022 | 36619896 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Airway Diseases: A Brief Overview of Recent Data. | Cancers (Basel) | 2022 | 36612051 | PubTator, text mining | PubMed |
| Editorial: Protection and healing in the digestive system and other tissues: Novel factors, mechanisms, and pharmaceutical targets. | Front Pharmacol | 2022 | 36605394 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of Genetic Factors from Human Blood Samples and Postmortem Brains in Parkinson's Disease. | Oxid Med Cell Longev | 2022 | 36593912 | PubTator, text mining | PubMed |
| Crosstalk between mitophagy and innate immunity in viral infection. | Front Microbiol | 2022 | 36590405 | PubTator, text mining | PubMed |
| Integrated molecular analyses of an interferon-γ based subtype with regard to outcome, immune characteristics, and immunotherapy in bladder cancer and experimental verification. | Heliyon | 2022 | 36582677 | PubTator, text mining | PubMed |
| The Role of N6-Methyladenosine in Inflammatory Diseases. | Oxid Med Cell Longev | 2022 | 36578520 | PubTator, text mining | PubMed |
| Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma. | Int J Clin Pract | 2022 | 36567775 | PubTator, text mining | PubMed |
| Apple Derived Exosomes Improve Collagen Type I Production and Decrease MMPs during Aging of the Skin through Downregulation of the NF-κB Pathway as Mode of Action. | Cells | 2022 | 36552714 | PubTator, text mining | PubMed |
| A Novel Gene Signature Associated with Inflammatory Responses and Immune Status Assists in Prognosis and Intervention for Patients with HCC. | J Inflamm Res | 2022 | 36536645 | PubTator, text mining | PubMed |
| Dysregulated inflammasome activity in intestinal inflammation - Insights from patients with very early onset IBD. | Front Immunol | 2022 | 36524121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=19